Advertisement Global Health Ventures signs licensing agreement with Globe Laboratories - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Global Health Ventures signs licensing agreement with Globe Laboratories

Global Health Ventures, a healthcare technology merchant bank, has signed a licensing agreement with Globe Laboratories, a privately-held biotechnology company in Vancouver, Canada.

Under the terms of the agreement, Globe Laboratories will license a new drug formulation for male sexual enhancement. The drug, which is in Phase I/II clinical trials, is expected to have a significant market once all trial studies and regulatory filings are completed.

The entire financing for the project will be committed by Global Health Ventures, while Globe Laboratories will benefit from marketing of the product through royalties, milestones, and research contracts agreed to by the two companies.